The Global Pulse Oximeters Market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/pulse-oximeters-market-100528

Some of the Main Key Players Covered in the Report

• Omron Healthcare, Inc.
• Philips Benelux
• General Electric Manufacturing Company (GEMAC)
• Masimo
• Messe Düsseldorf GmbH
• Vyaire Medical
• Opto Circuits India Ltd.
• Medtronic
• Nonin Medical, Inc

Masimo’s Approval for Radius PPG to Trigger Growth

In 2019, Masimo received clearance for its latest pulse oximeter. The ‘Radius PPG’ was approved by the FDA after establishing efficient results through clinical trials. The Radius PPG represents a significant breakthrough in the healthcare industry, particularly for the diagnosis and study of oxygen levels in the blood. The wireless ability allows users to move freely even when they are being examined with the device.

Masimo and Mindray Announce Partnership to Extend Sales Outside the US

In May 2019, Masimo and Shenzhen Mindray Biomedical Electronics announced that they have reached an agreement to extend the distribution of Masimo’s devices. Through this agreement, Mindray will offer sales and distribution options in countries other than the United States. The increasing demand for Masimo’s wrist-worn pulse oximeters has triggered this agreement, which in turn is likely to favor growth of the global market in the forthcoming years.

The report profiles several companies operating in the market and studies their growth strategies with regards to product launches and strategic collaborations. This is intended at evaluating the impact of these strategies on the overall market.

More Trending Topics from Fortune Business Insights:

https://www.fortunebusinessinsights.com/blog/dialyzer-market-9636

https://www.fortunebusinessinsights.com/blog/genomics-market-9290

https://www.fortunebusinessinsights.com/blog/wearable-medical-devices-market-9247

The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Leading Players operating in the Contraceptive Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Bayer AG

• Pfizer Inc.
• Janssen Global Services, LLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan Plc
• Agile Therapeutics

Piramal Enterprises Ltd

According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.

Rising Abortion Rates to Create Demand for Contraceptive Drugs

Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives. Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide. As per the World Health Organization, there is an estimated 40 to 50 million abortions every year, corresponding to an approximate of 125,000 abortions per day. To avoid unwanted and unplanned pregnancies, an increasing number of women are opting for contraceptive drugs. This will in turn augment growth in the global market.

Contrary to this, the market for contraceptive drugs may face challenges posed by religious, ethical, and social barriers especially in more conservative regions. Social taboos often discourage the use of contraceptive drugs among women, subsequently adversely impacting the overall market.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

More Trending Topics from Fortune Business Insights:

https://www.fortunebusinessinsights.com/blog/top-10-telemedicine-companies-2020-10077

https://www.fortunebusinessinsights.com/blog/globalization-during-covid-19-9775

https://www.fortunebusinessinsights.com/blog/coronavirus-pandemic-economic-impact-9721

The Global Telehealth Market is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Key players leading the global Telehealth Market include

• American Well,
• Teladoc Health,
• Doctor On Demand,
• GlobalMed,
• Dictum Health, Inc., LLC,
• InTouch Technologies, Inc.,
• MDLIVE Inc.,
• Encounter Telehealth,
• HelloMD,
• SnapMD, Inc.

The ability of Telehealth Market to access and manage healthcare services has led to their rising uptake across the world.  Telehealth is used to enhance healthcare services as well as increase feasibility within the healthcare services. Recent technological advancements in telehealth services have created huge potential for growth of the global telehealth market for the forthcoming years. The ability of telehealth services and products to reach out to rural areas and people who cannot access healthcare facilities has created a huge demand across the world. Resulting from such exceptional benefits for telehealth products, investors have identified this market as a gem and have identified several growth opportunities for the telehealth market companies around the world. Additionally, applications of telehealth in improving coordination and communication among the healthcare team will contribute to the increasing demand for telehealth products across the world.

Company Collaborations Are Proving Chief Growth Drivers

Due to the increasing demand, telehealth market companies are adopting collaborative strategies with the aim of expanding business on a global scale. Furthermore, leading companies in the telehealth industry are focusing on mergers and acquisitions to gain competitive strength. Companies are trying to incorporate modern industrial concepts with a view to gain more end users. Fortune Business Insights expects market collaborations will help companies generate substantial telehealth market revenue. In April 2018, American Well acquired Avizia Limited with the aim of strengthening its position among the companies in the telehealth industry. American Well’s acquisition of Avizia will help the company take a big leap in the telehealth market, owing to the exceptional portfolio of telehealth services bolstered by Avizia. The report includes company mergers, similar to American Well’s latest acquisition and signifies the impact of such M&As on the global telehealth market.

More Trending Topics from Fortune Business Insights:

Hemostats Market

Gene Therapy Market

Skin Diseases With Teledermatology

Vaccines Market

The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017. Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. Furthermore, the increasing number of deaths caused by malaria has impelled government and pharmaceutical companies to develop advanced vaccines. According to the latest world malaria report, released in November 2018, there were 219 million cases of malaria in 2017, up from 217 million cases in 2016. The estimated number of malaria death stood at 435 000 in 2017, a similar number to the previous year.

According to the report, published by Fortune Business Insights in a report, titled “Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route of Administration (Parenteral and Oral), By Disease Indication (Viral Diseases and Bacterial Diseases), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Region Forecast, 2019-2026

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

Some of the prominent companies in theVaccines Market are:

• GlaxoSmithKline plc.
• Sanofi
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Emergent BioSolutions, Inc.
• CSL Limited
• Inovio Pharmaceuticals, Inc.
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation.
• Other Prominent Players

Launch of Novel Vaccines to Enable Healthy Growth

The surge in the competitive pipeline, including products from the major players as well as emerging players will contribute positively to the market. The ongoing R&D and increasing focus on launching novel vaccines by key players will foster the growth of the market. The increasing demand for effective vaccines to fight diseases such as malaria, dengue has impelled pharmaceutical companies to launch novel vaccines. Companies such as Novavax, Inovio Pharmaceuticals, and Bavarian Nordic are among the top 10 players expected to have lucrative opportunities for their pipeline products in the forthcoming years.

Presence of Strong Manufacturers will Propel Growth in North America

North America generated a revenue of USD 22.03 billion in 2018 and is expected to remain dominant during the forecast period. The presence of strong manufacturers and secure government policies regarding human welfare will bolster growth in the region. Europe is expected to witness considerable growth during the forecast period. Diverse human vaccines policies across European countries such as Germany and France and robust government support will boost the vaccines market trends in Europe.

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098

However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.

Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:

• uFluidix
• Perkin Elmer
• Fluidigm
• Blacktrace Holdings Ltd. (Dolomite Microfluidic)
• Micronit
• BioFluidix GmbH‎
• Fluigent
• ALine, Inc.
• Philips
• Other prominent players

Schott AG Acquires MINIFAB to Develop Top-quality Polymer and Glass Solutions

Schott AG, a company specializing in the production of glass and glass-ceramics, based in Germany, declared that it has completed its acquisition of MINIFAB PTY Ltd., a provider of custom-designed and manufactured microfluidic and medical devices, based in Australia in June 2019. This strategic collaboration will enable both companies to upgrade their portfolios in the diagnostics market. They will be able to provide the products to their existing consumers as well as serve new consumers effectively in the upcoming years by developing centers of excellence for glass in Germany and polymer in Australia.

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

List of the companies functioning in the global market are

• LFB
• Shire
• Japan Blood Products Organization
• Biotest AG
• Grifols, S.A.
• C. Pharma (Green Cross Corporation)
• Octapharma
• Sanquin
• Kedrion S.p.A.
• Baxter
• China Biologic Products
• CSL
• Shanghai RAAS Blood Products

Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for Market

The rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation. This is a major factor boosting the overall market. In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market. Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market

North America Emerges Dominant on Account of Better Healthcare Infrastructures

Geographically, the global market for plasma fractionation is dominated by North America at present. Factors promoting growth in this region are better healthcare infrastructures, government supported reimbursement policies, and presence of large company in developed nations of the region namely Canada and the U.S. Moreover, recent approvals from the Food and Drug (FDA) favor the growth of new plasma fractionation facilities are thus creating lucrative growth opportunities for the market in North America. For instance, the FDA approved a plasma fractionation facility in Melville for Kedrion S.P.A. in February 2019.

The Global Diabetes Devices Market is anticipated to exhibit an impressive CAGR of 5.5% on account of rising prevalence of diabetes. Key insights into this fast growing market, valued at US$ 32,441.3 mn in 2018, have been shared by Fortune Business Insights in its report, titled “Diabetes Devices Market Size, Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast till 2026”. The report brings out the key aspects that will influence the market in the forecast period. Diabetes is a metabolic disease in which the body is unable to process glucose, leading to elevated levels of blood sugar.

This happens as the body does not make enough insulin (a hormone made by the pancreas), which helps the glucose enter the cells and supply the body with energy to function. Diabetes devices such as insulin pumps and continuous glucose monitors are used by medical professionals and patients to regulate and monitor blood glucose levels.

Browse Complete Report Details@

https://www.fortunebusinessinsights.com/industry-reports/diabetes-devices-market-100803

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Diabetes Devices market. Some of the companies operating the global Diabetes Devices market are;

• Hoffmann-La Roche Ltd.
• Medtronic
• Tandem Diabetes Care, Inc.
• BD
• Eli Lilly
• Company
• Sanofi

Certain Misgivings May Restrain Market Growth

The global diabetes devices market is expected to grow on the basis of steadily rising adoption rates of various monitoring devices. However, certain devices entail a few risks, which may cast a shadow of doubt in the minds of consumers. For example, insulin pumps are very convenient and efficient way to administer the required amount of insulin into the body. But, there is a fear that patients might get infected at the catheter site. Insulin pumps are also expensive, which can push people to avail traditional methods of diabetes care. Similarly, continuous glucose monitors (CGMs) are known to be inaccurate, especially in case of drop in glucose levels. This is mainly because the technology is still developing. CGMs are also known to be expensive.

The global orthopedic implants market size is set to touch USD 64.0 billion by 2026, exhibiting a modest CAGR of 4.1% during the forecast period. Unprecedented rise in geriatric population across the globe to be the key growth driver of this market. According to the United States Census Bureau (USCB), the proportion of aged people to the total world population is steadily climbing. For example, in 2012, world population had reached 7 billion and the people aged 65 and above were 8% of this number or 562 million.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/orthopedic-implants-market-101659

Some of the key players in this market include:

• BioTek Instruments, Inc.
• Zimmer Biomet
• Integra LifeSciences Corporation
• DePuy Synthes Companies (Johnson & Johnson Services, Inc.)
• ArthroCare Corporation
• Medtronic
• CONMED Corporation
• Smith & Nephew

In 2015, the number rose by 55 million, with the percentage increasing to 8.5% of the total population in a span of 3 years. The USCB predicts that between 2025 and 2050, this geriatric population will double to reach 1.6 billion, whilst the total population will grow only by 34%.

This, the USCB states, is attributable to the reduction in fertility rates around the world and lengthening lifespans due to advancements in medical technologies. This is expected to substantially broaden the base of the market, especially the joint reconstruction segment, as per the orthopedic implants market trends.

According to the report by Fortune Business Insights, titled “Orthopedic Implants Market Size, Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants;Trauma Implants,Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026”, the market value stood at USD 46.5 billion in 2018. The report also incorporates a thorough analysis of the factors, upcoming trends, and dynamics that are likely to influence the growth trajectory of the market. The in-depth research contained in the report aims at equipping businesses with adequate information that will enable them to make informed decisions and strategies for the future.

North America to Hold a Commanding Position; Europe to Grow at an Impressive Rate

Among regions, North America is expected to dominate the global orthopedic implants market share owing to the increasing incidence of osteoarthritis in the region. Europe is projected to grow at a considerable rate on account of rapid spread of chronic diseases such as diabetes and obesity in the continent. In Asia-Pacific, rise in healthcare expenditure and increasing disposable incomes will propel the market in the region, as per the orthopedic implants market analysis by Fortune Business Insights. However, the market growth in Africa, Latin America, and the Middle East is anticipated to be slow due to low levels of development in these regions.

The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market. According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.

 For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063

Leading Players operating in the Contraceptive Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Bayer AG

• Pfizer Inc.
• Janssen Global Services, LLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan Plc
• Agile Therapeutics
• Piramal Enterprises Ltd.

Rising Abortion Rates to Create Demand for Contraceptive Drugs

Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives. Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide. As per the World Health Organization, there is an estimated 40 to 50 million abortions every year, corresponding to an approximate of 125,000 abortions per day. To avoid unwanted and unplanned pregnancies, an increasing number of women are opting for contraceptive drugs. This will in turn augment growth in the global market.

Contrary to this, the market for contraceptive drugs may face challenges posed by religious, ethical, and social barriers especially in more conservative regions. Social taboos often discourage the use of contraceptive drugs among women, subsequently adversely impacting the overall market.